ÇѸ²´ëÃáõ¼º½Éº´¿ø ºñ´¢±â°ú ÀÌ¿ø±â ±³¼ö(»çÁø)°¡ Áö³ 5ÀÏ ¼¿ï»ï¼ºÀÇ·á¿ø¿¡¼ ¿¸° ‘´ëÇѳ²¼º°úÇÐȸ Á¦ 31Â÷ Çмú´ëȸ °â ´ëÇÑ¿©¼º¼º°Ç°¿¬±¸È¸ Á¦14Â÷ Çмú´ëȸ’¿¡¼ Çмú»óÀ» ¼ö»óÇß´Ù.
ÀÌ ±³¼ö´Â ¼ºÀÇÇÐ ºÐ¾ß¿¡¼ ±¹Á¦ÀûÀ¸·Î °¡Àå ±ÇÀ§ ÀÖ´Â Àú³Î ‘Journal of Sexual Medicine'¿¡ °ÔÀçÇÑ ’Comparison between on-demand dosing of dapoxetine alone and dapoxetine plus mirodenafil in patients with lifelong premature ejaculation: prospective, randomized double-blind, placebo-controlled multicenter study‘ ³í¹®ÀÇ ¿ì¼ö¼ºÀ» ÀÎÁ¤¹Þ¾Æ »óÀ» ¹Þ¾Ò´Ù.
ÀÌ ³í¹®Àº Æ÷½ºÆ÷µð¿¡½ºÆ®¶óÁ¦-5 ¾ïÁ¦Á¦¸¦ Åõ¾à, Ä¡·á¹æ¹ýÀÌ ¸¹Áö ¾ÊÀº Á¶·ç(premature ejaculation)ÀÇ Ä¡·á È¿°ú¸¦ ÀÓ»óÀûÀ¸·Î ÀÔÁõÇØ Ä¡·áÀÇ ÆøÀ» ³ÐÇû´Ù´Â ÆòÀ» ¹Þ¾Ò´Ù.
Æ÷½ºÆ÷µð¿¡½ºÆ®¶óÁ¦-5 ¾ïÁ¦Á¦´Â ¹ß±âºÎÀüÀ̳ª Àü¸³¼± ºñ´ëÁõÀÇ Ä¡·áÁ¦·Î ÁÖ·Î »ç¿ëµÅ ¿ÔÁö¸¸ FDA ½ÂÀÎÀ» ¹ÞÀº ´ÙÆø¼¼Æ¾°ú ÇÔ²² º´¿ëÇßÀ» ¶§ Á¶·ç¿¡ ±àÁ¤ÀûÀÎ È¿°ú°¡ ÀÖ´Ù´Â °ÍÀ» È®ÀÎÇØ ³Â´Ù.
ÀÌ ±³¼ö´Â Áö³ 2011³â°ú 2013³â¿¡µµ ÀÌ Çмú´ëȸ¿¡¼ ÃÖ¿ì¼ö ¹ßÇ¥ »óÀ» ¹Þ¾Ò´Ù.
ÀÌ ±³¼ö´Â ÇöÀç ÇѸ²´ëÃáõ¼º½Éº´¿ø ºñ´¢±â°ú °úÀåÀ¸·Î ±¹Á¦¼ºÀÇÇÐȸ Á¤È¸¿ø, ¾Æ½Ã¾ÆÅÂÆò¾ç ¼ºÀÇÇÐȸ °£ÇàÀ§¿ø, ¾Æ½Ã¾Æºñ´¢±â°úÇÐȸÁö ½É»çÀ§¿ø, ´ëÇѺñ´¢±â°úÇÐȸÁö ÆíÁýÀ§¿ø, ´ëÇѳ²¼º°úÇÐȸ ÀÌ»ç¿Í ¿¬±¸À§¿øÀ¸·Î È°µ¿ ÁßÀÌ´Ù.